Aplab Limited (BOM:517096)

Sage Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 25, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	545	559	822	303	250	86
Market Cap Growth	-32.00%	-32.00%	171.39%	21.12%	189.85%	217.10%
Enterprise Value	806	830	1,115	789	821	789
Last Close Price	43.32	30.94	45.50	18.59	15.35	7.37
PE Ratio	188.35	211.78	102.82	147.90	145.09	-
PS Ratio	0.86	0.88	1.66	0.59	0.49	0.16
PB Ratio	5.25	5.39	8.12	-1.53	-1.20	-0.33
P/TBV Ratio	5.27	5.41	11.35	-	-	-
P/FCF Ratio	55.82	57.29	-	-	1.38	-
P/OCF Ratio	28.87	29.63	-	-	1.34	-
EV/Sales Ratio	1.27	1.30	2.25	1.53	1.60	1.49
EV/EBITDA Ratio	-	-	23.80	13.70	11.40	12.12
EV/EBIT Ratio	-	-	26.27	14.86	12.04	12.86
EV/FCF Ratio	82.63	85.10	-	-	4.53	-
Debt / Equity Ratio	2.89	2.89	2.56	-2.53	-2.29	-2.75
Debt / EBITDA Ratio	-	-	5.54	8.71	6.62	11.01
Debt / FCF Ratio	30.68	30.68	-	-	2.63	-
Asset Turnover	0.90	0.90	0.68	0.73	0.66	0.58
Inventory Turnover	1.43	1.43	0.63	0.83	1.24	1.49
Quick Ratio	0.56	0.56	0.47	0.37	0.28	0.42
Current Ratio	1.02	1.02	1.04	0.70	0.49	0.59
Return on Equity (ROE)	2.57%	2.57%	-	-	-	-
Return on Assets (ROA)	-2.98%	-2.98%	3.61%	4.68%	5.46%	4.19%
Return on Capital (ROIC)	-5.51%	-5.51%	7.98%	11.60%	11.76%	8.46%
Return on Capital Employed (ROCE)	-	-	22.80%	-	-	-
Earnings Yield	0.48%	0.47%	0.97%	0.68%	0.69%	-4.49%
FCF Yield	1.79%	1.75%	-4.85%	-14.54%	72.41%	-17.10%
Buyback Yield / Dilution	17.82%	17.82%	-39.60%	-	-100.00%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.